Guest guest Posted December 5, 2008 Report Share Posted December 5, 2008 (DLI) is for patients with relapsed chronic myelogenous leukemia (CML) after allogeneic hematopoietic stem cell transplantation. Purified recombinant 8 was used to generate a 8-specific murine monoclonal antibody. This is an abstract from the American Association for Cancer Research. http://cancerres.aacrjournals.org/cgi/content/full/62/19/5517?maxtoshow= & HITS=10\ & hits=10 & RESULTFORMAT= & searchid=1 & FIRSTINDEX=0 & minscore=5000 & resourcetype=HWCIT FYI Lottie Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.